3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
2
Venous Thrombosis
1
Thrombosis
1
Sarcoma
1
Pulmonary Embolism
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Fractures, Spontaneous
1
Femoral Fractures
1
Bone Neoplasms
1
Interventions
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
apixaban
1
X-Rays
1
Warfarin
1
Technetium Tc 99m Sulfur Colloid
1
Saline Solution
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Paclitaxel
1
Musculoskeletal Manipulations
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Dexmedetomidine
1
Dalteparin
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thrombosis
×
Dalteparin
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts